EMAIL DETAILS

Dear Eric,
please find attached the signed NDA.
Ciao
Corrado


________________________________________
From: Eric Schwerin [eschwerin@rosemontseneca.com]
Sent: 04 December 2014 18:38
To: Corrado Cusano
Cc: rhb@rspdc.com
Subject: Re: MedTAG NDA and Introduction agreement

Corrado, in the meantime, attached is the executed NDA.


Eric D. Schwerin
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com
P Consider the environment before printing this email.

On Dec 4, 2014, at 12:21 PM, Corrado Cusano <corrado.cusano@medtag.net<mailto:corrado.cusano@medtag.net>> wrote:

Good. Ready to go to Astana!
Thanks and regards
Corrado


On 04/dic/2014, at 18:13, Eric Schwerin <eschwerin@rosemontseneca.com<mailto:eschwerin@rosemontseneca.com>> wrote:

Thanks, Corrado. It was good speaking with you as well. We’ll review this ASAP and get it back to you with any changes.

Glad we have a good plan.

Best,

Eric


Eric D. Schwerin
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com
P Consider the environment before printing this email.

On Dec 3, 2014, at 1:37 PM, Corrado Cusano <corrado.cusano@medtag.net<mailto:corrado.cusano@medtag.net>> wrote:

Dear Hunter and Eric,

it was nice to speak to you on the phone before.
As agreed please find attached our NDA and our introduction agreement.
Feel free to make any changes you consider necessary.
The fee mentioned in the agreement covers your side (you and your local partner).
As I told you I have already a separate agreement with Franco Nuschese.
This looks to me like a great opportunity.
I'm available to go there or invite them to see our centre when you like.
Look forward to hearing from you.
Many thanks and best regards

Corrado


Corrado Cusano
President & CEO
_________________
MEDTAG Ltd
England
12, Bridewell Place, 3rd Floor, East Unit
London EC4V 6AP

www.medtag.net<http://www.medtag.net/>

The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination of this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from any computer.<RSP_Medtag.docx><RSP_Medtag_NDA.doc>